ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
HORIZON KINETICS MEDICAL ETF
34.96
-0.3314
-0.94%
成交量：
588
成交額：
2.06萬
市值：
1,642.82萬
市盈率：
- -
高：
35.04
開：
34.99
低：
34.96
收：
35.29
52周最高：
37.90
52周最低：
28.87
股本：
46.99萬
流通股本：
46.99萬
量比：
0.27
換手率：
0.13%
股息：
0.41
股息率：
1.17%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
廣州金堃醫學檢驗實驗室有限公司成立
同花顺
·
09/04
中國銀河證券：創新藥產業鏈高景氣 商業化與對外授權變現打開成長空間
智通财经网
·
09/04
里昂：生物科技行業基本面仍穩固，首選百濟神州、信達生物及維立志博
智通财经
·
09/04
從護膚到大健康，植物醫生想成為一家生物科技公司
蓝鲸财经
·
09/04
創新藥板塊活躍 昂利康漲停
同花顺
·
09/04
更多創新藥有望納入醫保報銷
格隆汇
·
09/04
創新藥概念表現活躍 昂利康逼近漲停
智通财经
·
09/04
109億美元重磅收購Apogee(APGE.US)落地！艾伯維(ABBV.US)完成2019年以來最大併購，預計2032年起貢獻收益
智通财经
·
09/04
109億美元重磅收購Apogee(APGE.US)落地！艾伯維(ABBV.US)完成2019年以來最大併購，預計2032年起貢獻收益
智通财经
·
09/04
創新藥項目報價「水漲船高」，CRO行業下半年或加速回暖
智通财经
·
09/04
艾伯維公布Cervino三期試驗積極頂線結果：Etentamig顯著提升復發/難治性多發性骨髓瘤患者緩解率與無進展生存期
美股速递
·
09/03
艾伯維的血液癌症藥物達到了晚期臨床試驗的目標
路透中文
·
09/03
阿斯彭預計，2027年Mounjaro在非洲的銷售額將超過1.24億美元
路透中文
·
09/03
通用電氣維諾華公司：與愛爾蘭國家電力公司達成協議，將為蘇格蘭高地的96兆瓦奇倫塞德風電場供應16台6.1兆瓦-158米型
智通财经
·
09/03
2026醫保國談將於9月5日舉行
格隆汇
·
09/03
創新藥熱浪來襲，如何把握投資機會？
新浪基金
·
09/03
Superluminal Medicines完成融資：Bvf Partners領投，英偉達、禮來等現有投資方跟投
美股速递
·
09/03
浩歐博(688656.SH)子公司獲得13項醫療器械註冊證
智通财经
·
09/03
康哲藥業(00867)：創新藥磷酸蘆可替尼乳膏百盧妥®增加特應性皮炎適應症(AD) 中國上市許可申請獲批
智通财经
·
09/03
一品紅(300723.SZ)：痛風創新藥AR882治療痛風伴高尿酸血癥患者Ⅲ期臨床研究達到主要終點
智通财经
·
09/03
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/MEDX/news?page=12"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":34.9577,"timestamp":1789502400000,"preClose":35.2891,"halted":0,"volume":588,"delay":0,"changeRate":-0.009391001754082565,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"盤前交易","change":-0.3314,"latestTime":"09-16 07:50:32 EDT","open":34.99,"high":35.04,"low":34.9577,"amount":20606,"amplitude":0.002332,"askPrice":37,"askSize":35,"bidPrice":34.05,"bidSize":15,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":34.9577,"sharesOutstanding":569946,"nav":35.26,"aum":16570295.96,"dividendRate":0.0117,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.04,"preClose":34.9577,"latestTime":"16:10 EDT","volume":6,"amount":209.6308,"timestamp":1789503007392,"change":0.0823,"changeRate":0.002354,"amplitude":0},"volumeRatio":0.2679303977521077},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.2679303977521077,"shares":469946,"dividePrice":0.409,"high":35.04,"amplitude":0.002332,"preClose":35.2891,"low":34.9577,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":34.9577,"committee":-0.4,"eps":0,"divideRate":0.0117,"volume":588,"delay":0,"ttmEps":0,"open":34.99,"prevYearClose":33.2024,"prevWeekClose":34.9572,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":35.4213,"twentyDayClose":35.8903,"sixtyDayClose":33.8763},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:12,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664387724","title":"廣州金堃醫學檢驗實驗室有限公司成立","url":"https://stock-news.laohu8.com/highlight/detail?id=2664387724","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664387724?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 16:08","pubTimestamp":1788509280,"startTime":"0","endTime":"0","summary":" 本报讯(记者袁传玺)企查查APP显示，近日，广州金堃医学检验实验室有限公司成立，注册资本为1000万元，经营范围包含：健康咨询服务(不含诊疗服务)；第一类医疗器械 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260904/c679607419.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260904/c679607419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664238064","title":"中國銀河證券：創新藥產業鏈高景氣 商業化與對外授權變現打開成長空間","url":"https://stock-news.laohu8.com/highlight/detail?id=2664238064","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664238064?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 15:54","pubTimestamp":1788508491,"startTime":"0","endTime":"0","summary":"上半年行业利润增长显著快于收入，主要系创新药商业化收入及对外授权收入增加，高毛利业务占比大幅提升，同时CXO和科研服务呈高景气度，订单增长驱动前期产能建设和人员储备充分利用，摊薄固定成本并推动利润增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0188","BK1147","IBBQ","159992","LNGR","BK1564","06881","601881","06978","MEDX","BK1574","161027","BK1161","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664381419","title":"里昂：生物科技行業基本面仍穩固，首選百濟神州、信達生物及維立志博","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381419","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381419?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 14:16","pubTimestamp":1788502604,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","LNGR","ONC","IEIH","BK4526","AGNG","BK4588","BK4585","SYNB","XBI","BK4581","MEDX","GDOC","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664381446","title":"從護膚到大健康，植物醫生想成為一家生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381446","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381446?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 12:39","pubTimestamp":1788496793,"startTime":"0","endTime":"0","summary":"从高山植物护肤，到中国原创成分，再到大健康产品，它正在尝试把高山植物科研从服务于单一护肤品的研发能力，变成一套能够跨品类持续产生价值的科研底座。这个问题的答案，将决定植物医生最终是增加了一条大健康产品线，还是能够真正完成从护肤品牌向生物科技公司的能力跃迁。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788496062591431273","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["SYNB","BK4588","IBBJ","LNGR","MEDX","XBI","159837","BK4581","IEIH","BK4585","AGNG","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664385956","title":"創新藥板塊活躍 昂利康漲停","url":"https://stock-news.laohu8.com/highlight/detail?id=2664385956","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664385956?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 10:57","pubTimestamp":1788490620,"startTime":"0","endTime":"0","summary":"上证报中国证券网讯(记者冯心怡)9月4日早盘，创新药板块表现活跃，昂利康涨停，报27.86元/股，涨幅为9.99%。昂利康坚持“仿制药—改良型新药—创新药”的研发布局。据新华社9月4日消息，国 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260904/c679599107.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260904/c679599107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["159992","IBBQ","BK1161","MEDX","LNGR","BK0239","002940","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664383252","title":"更多創新藥有望納入醫保報銷","url":"https://stock-news.laohu8.com/highlight/detail?id=2664383252","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664383252?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 10:20","pubTimestamp":1788488426,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IBBQ","PSCH","BK1161","06978","BK4588","MEDX","159992","BK1574","ENTL","HART","IHI","LNGR","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664383834","title":"創新藥概念表現活躍 昂利康逼近漲停","url":"https://stock-news.laohu8.com/highlight/detail?id=2664383834","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664383834?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 09:47","pubTimestamp":1788486451,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","MEDX","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664388058","title":"109億美元重磅收購Apogee(APGE.US)落地！艾伯維(ABBV.US)完成2019年以來最大併購，預計2032年起貢獻收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2664388058","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664388058?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 09:35","pubTimestamp":1788485746,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4533","FTXH","JDOC","RXL","APGE","LU0234570918.USD","LU0114720955.EUR","GLAM","LU2237443549.SGD","SG9999003800.SGD","IE0002141913.USD","IYH","PPH","LU1236620834.HKD","CALF","FHLC","LU2125909593.SGD","LU2087621335.USD","KCE","LU0124676726.USD","IE00B19Z3B42.SGD","LU0203345920.USD","SBIO","LU0820561909.HKD","AGNG","TRUH","LU2433249047.HKD","XMMO","LU0310800379.SGD","LU2237443895.HKD","MYLD","PJP","LU2129689514.USD","LU0170899867.USD","LU2129689605.HKD","IE000WAW04H5.SGD","LU0128525929.USD","LU1839511570.USD","LU1496350502.SGD","VHT","LU0069063385.USD","LU2089984988.USD","MEDX","IXJ","LU1551013425.SGD","LU1267930490.SGD","ABBV","LU0320765646.SGD","XLV","LU0859254822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664053388","title":"109億美元重磅收購Apogee(APGE.US)落地！艾伯維(ABBV.US)完成2019年以來最大併購，預計2032年起貢獻收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2664053388","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664053388?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 09:35","pubTimestamp":1788485746,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，艾伯维于周四表示，公司已完成对抗炎药物研发商 Apogee Therapeutics价值 109 亿美元的收购。笔交易是这家制药巨头自 2019 年以来规模最大的补强型收购，智通财经AAPP于今年 6 月首次对此进行了报道。艾伯维预计，该项收购将对其调整后稀释每股收益产生负面影响，其中 2026 年将减少 0.14 美元，2027 年减少约 0.46 美元，并预计将于 2032 年开始实现增益。该指引已包含与完成 Apogee 收购相关的每股 0.14 美元稀释效应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0124676726.USD","IXJ","KCE","GLAM","IE00B2B36J28.USD","LU0256863902.USD","LU1989772840.SGD","VHT","FTXH","LU1934455194.USD","LU1718418525.SGD","RXL","IE00BN8TJ469.HKD","FHLC","APGE","IE00BLSP4239.USD","LU0057025933.USD","LU0289739343.SGD","LU2089283258.USD","IE0002270589.USD","LU2237443549.SGD","XLV","LU0203345920.USD","CALF","BK4559","LU1236620834.HKD","MEDX","IE00B4R5TH58.HKD","LU1003077747.HKD","LU0985320562.USD","TRUH","BK4581","BK4566","IYH","LU0170899867.USD","SG9999011175.SGD","IE0004445239.USD","XMMO","LU1983299246.USD","MYLD","PJP","LU0965509283.SGD","LU1093756168.USD","LU1037948541.HKD","PPH","SBIO","IE00B19Z3581.USD","ABBV","AGNG","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664280253","title":"創新藥項目報價「水漲船高」，CRO行業下半年或加速回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2664280253","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664280253?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 06:23","pubTimestamp":1788474180,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","LNGR","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112455320","title":"艾伯維公布Cervino三期試驗積極頂線結果：Etentamig顯著提升復發/難治性多發性骨髓瘤患者緩解率與無進展生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1112455320","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112455320?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 21:19","pubTimestamp":1788441558,"startTime":"0","endTime":"0","summary":"艾伯维公司今日宣布，其针对复发或难治性多发性骨髓瘤患者的关键性Cervino三期临床试验，取得了积极的顶线数据。研究结果显示，在研药物Etentamig不仅显著提高了患者的客观缓解率，更在延长无进展生存期方面展现出压倒性的统计学优势。Cervino试验是一项全球性的、随机、开放标签的注册研究，旨在评估Etentamig相较于标准治疗的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","LU2129689514.USD","LU0198837287.USD","LU1718418525.SGD","SG9999003800.SGD","PPH","LU1267930490.SGD","LU1074936037.SGD","LU1003077747.HKD","IE0002270589.USD","LU1430594728.SGD","LU1983299246.USD","IE00BSNM7G36.USD","IYH","IE00BLSP4452.SGD","LU1989772840.SGD","LU2237443549.SGD","LU0472753341.HKD","MEDX","LU1934455194.USD","LU1585245621.USD","LU0122379950.USD","IE000MB6IJN5.SGD","LU0726765562.USD","LU1670627923.USD","LU2433249047.HKD","BK4581","SG9999001440.SGD","LU1244550577.SGD","LU0795875169.SGD","SG9999015952.SGD","IE00BGHQF631.EUR","LU0708994859.HKD","LU1061106388.HKD","LU0058720904.USD","LU0158827948.USD","BK4585","IE00BBT3K403.USD","LU0098860793.USD","LU0211327993.USD","IE00B19Z3581.USD","AGNG","SG9999015986.USD","LU1989771016.USD","IE0000B7K699.USD","LU2129689605.HKD","LU1093756325.SGD","XLV","LU1162221912.USD","BK4139","LU2133065610.SGD","LU2468319806.SGD","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","LU1839511570.USD","IE00BVYPNW00.USD","LU2089284900.SGD","LU0289739343.SGD","LU1244550494.USD","IE0002141913.USD","BK4566","LU0823416689.USD","BK4533","LU1496350171.SGD","TRUH","LU0965509010.AUD","LU0511384066.AUD","LU0942090050.USD","LU0820561818.USD","SG9999015945.SGD","VHT","LU1551013425.SGD","LU2357627491.SGD","SG9999015978.USD","LU0965509101.SGD","LU1934455277.USD","LU2125909593.SGD","LU0949170772.SGD","BK4550","LU0965509283.SGD","LU0661504455.SGD","LU0256863811.USD","LU1267930573.SGD","GLAM","IE000WAW04H5.SGD","LU0545039389.USD","LU0289739699.SGD","LU2129689431.USD","LU1732800096.USD","LU0320765646.SGD","LU0795875086.SGD","LU1732799900.SGD","LU0912757837.SGD","LU2112291526.USD","LU0868494617.USD","LU0114720955.EUR","LU2089984988.USD","IE00B4R5TH58.HKD","IE000BZT7R73.USD","LU0553294199.USD","LU2237443622.USD","LU0417517546.SGD","LU0310800379.SGD","ABBV","LU0256863902.USD","LU2347655073.USD","LU0069063385.USD","IE00B3PB1722.GBP","JDOC","IE00BN8TJ469.HKD","LU0234572021.USD","RXL","LU0965508806.USD","LU0689626769.HKD","LU0868494708.USD","LU1037948897.HKD","BK4559","LU1923622614.USD","LU0456855351.SGD","LU1934455863.HKD","IE00BLSP4239.USD","LU2087621335.USD","FHLC","LU0820561909.HKD","IE00BVYPNV92.GBP","LU0882574055.USD","LU0124676726.USD","LU0128525929.USD","LU1236620834.HKD","LU2237443895.HKD","LU0395794307.EUR","PJP","IE00BFTCPJ56.SGD","LU2023251221.USD","IXJ","LU0738911758.USD","LU0289961442.SGD","IE0009355771.USD","LU2237443465.HKD","LU1244550221.USD","LU1989772923.USD","LU1929549753.HKD","IE00B2B36J28.USD","LU0859254822.USD","SG9999011175.SGD","LU2089283258.USD","LU0985320562.USD","BK4534","LU2125909247.SGD","IE00B42XCP33.USD","LU0203347892.USD","LU1037948541.HKD","LU0432979614.USD","LU1093756168.USD","LU1291159041.SGD","LU0029864427.USD","LU1670628061.USD","LU1236620750.USD","LU2237443382.USD","LU2237443978.SGD","LU0861579265.USD","LU1551013342.USD","LU0310799852.SGD","LU0943347566.SGD","BK4588","LU0057025933.USD","LU0234570918.USD","IE0004445239.USD","LU0170899867.USD","IE000SO60NU8.SGD","LU1023059063.AUD","LU0211328371.USD","FTXH","IE00BJJMRZ35.SGD","LU1496350502.SGD","IE000F7OJYX1.SGD","LU2347655156.SGD","LU1057294990.SGD","IE00BDGV0183.EUR","LU0689472784.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664287786","title":"艾伯維的血液癌症藥物達到了晚期臨床試驗的目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2664287786","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664287786?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 21:18","pubTimestamp":1788441535,"startTime":"0","endTime":"0","summary":"艾伯维的血液癌症药物达到了晚期临床试验的目标路透9月3日-艾伯维（AbbVie）ABBV.N周四表示，其用于治疗某类血液癌症的药物已达到一项晚期临床试验的主要目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4T44V12O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","LU1732800096.USD","LU0795875169.SGD","LU0942090050.USD","SG9999011175.SGD","LU2125909593.SGD","LU2237443382.USD","LU1244550494.USD","LU1934455194.USD","PJP","IE00B2B36J28.USD","LU0170899867.USD","LU0289961442.SGD","IE00B19Z3B42.SGD","SG9999001440.SGD","ABBV","LU2089283258.USD","LU1430594728.SGD","LU0511384066.AUD","GLAM","IE000WAW04H5.SGD","VHT","FHLC","IXJ","BK4588","LU0456855351.SGD","LU1093756325.SGD","LU0545039389.USD","LU1989771016.USD","FTXH","JDOC","LU0861579265.USD","TRUH","XLV","LU1934455863.HKD","RXL","IE00BBT3K403.USD","LU0128525929.USD","IE00B3PB1722.GBP","IYH","LU2237443465.HKD","MEDX","PPH","LU1244550577.SGD","LU1839511570.USD","SG9999003800.SGD","SG9999015945.SGD","LU0234572021.USD","LU0859254822.USD","LU0943347566.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874779","title":"阿斯彭預計，2027年Mounjaro在非洲的銷售額將超過1.24億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874779","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874779?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 20:37","pubTimestamp":1788439031,"startTime":"0","endTime":"0","summary":"阿斯彭预计，2027年Mounjaro在非洲的销售额将超过1.24亿美元阿斯彭已向肯尼亚和尼日利亚提交了Mounjaro的注册申请截至6月底的这一年度内，南非GLP-1市场规模几乎翻倍，达到28亿兰特阿斯彭计划在部分市场推出奥兹莫皮克仿制药，巴西也在其中Nqobile Dludla路透约翰内斯堡9月3日-阿斯彭制药预计，在南非需求激增以及计划在尼日利亚和肯尼亚上市的推动下，礼来公司旗下LLY.N这款重磅减肥及糖尿病药物Mounjaro在本财年的非洲销售额将超过20亿兰特。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4S44V0ZN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999017495.SGD","LU1551013342.USD","IE0002141913.USD","WDNA","LLYZ","LU2211815571.USD","LU0061475181.USD","LU0096364046.USD","LU0320765059.SGD","LU2168564065.EUR","IE00B4JS1V06.HKD","LU0708995401.HKD","LU2237443382.USD","LU2361044949.HKD","IE00BFTCPJ56.SGD","SG9999015986.USD","LU1868837136.USD","LU2552382215.SGD","LU1979441026.SGD","LU2491049909.HKD","TMED","SG9999018857.SGD","IE0004445015.USD","LLII","LU0432979614.USD","MEDI","LU2265009873.SGD","LLY","LU0345770308.USD","LU2106854487.HKD","JDOC","LU0256863902.USD","LU1023059063.AUD","LU2462591350.SGD","LU2087625088.SGD","IE00BJJMRZ35.SGD","IE00BJLML261.HKD","LU2468319806.SGD","SG9999014898.SGD","LU1232071149.USD","LU2023250504.SGD","SGXZ51526630.SGD","LU2112291526.USD","LU0417517546.SGD","LU1868836914.USD","IE00B1BXHZ80.USD","LU0158827948.USD","LU2237443622.USD","LLYX","LU1804176565.USD","BK4516","LU2552382058.USD","OZEM","LU2360106947.USD","LU1983299246.USD","IE0001KFT4U8.USD","IE0009355771.USD","LU0158827781.USD","LU0882574139.USD","IE00BJT1NW94.SGD","LU0943347566.SGD","LU1069344957.HKD","LU1127390331.HKD","FTXH","LU0889565916.HKD","LU1291159041.SGD","BK4534","LU1691799644.USD","LU1868836757.USD","MEDX","SGXZ31699556.SGD","IE00BJJMRX11.SGD","LU0672654240.SGD","LU1280957306.USD","LU2237438978.USD","BK4581","LU2023251221.USD","LU2361045086.USD","IXJ","CURE","LU2089284900.SGD","LU2456880835.USD","IE00BKDWB100.SGD","LU1720051017.SGD","SG9999001176.SGD","LU0964807845.USD","LU2602419157.SGD","LU0466842654.USD","LU0640476718.USD","SG9999014914.USD","LU0266013472.USD","LU0114720955.EUR","LU2168563687.JPY","LU1868836591.USD","LU0198837287.USD","LU2089283258.USD","LU2746668461.USD","LU0097036916.USD","IE00BFSS8Q28.SGD","ELIS","LU2462157665.USD","LU0234572021.USD","LU0786609619.USD","LU0109391861.USD","LU0882574055.USD","LU2361044865.SGD","IE00B4R5TH58.HKD","LU2750360641.GBP","LU2756315664.SGD","LU2471134523.USD","RXL","LU2089984988.USD","IE0005OL40V9.USD","LU0320765992.SGD","LU0006306889.USD","LU0289739699.SGD","LU1035775433.USD","LU1064131342.USD","LU1548497426.USD","LU1057294990.SGD","LU2168564149.EUR","PPH","IE0004445239.USD","SGXZ57979304.SGD","LU1623119135.USD","LU2357305700.SGD","SG9999015978.USD","LU2750360997.AUD","THNR","LU2168564222.USD","LU2471134796.USD","IE00BN29S564.USD","LU2746668974.SGD","LU0823416689.USD","LU0203201768.USD","LU0094547139.USD","SG9999018865.SGD","LU1814569148.SGD","LU1868837300.USD","IE00B7KXQ091.USD","LU1989771016.USD","BK4533","BK4599","LU2461242641.AUD","APNHY","LU2417539215.USD","LU2023250330.USD","LU0106261372.USD","SGXZ81514606.USD","VHT","GDOC","LU0471298777.SGD","IE00BFSS7M15.SGD","LU0345770993.USD","LU2236285917.USD","LU2237443549.SGD","IE00B775H168.HKD","LU0122379950.USD","LU0354030511.USD","LU0385154629.USD","LU0683600562.USD","LU2168564495.EUR","LU2491050071.SGD","SG9999015952.SGD","LU2271345857.HKD","IE00BK4W5L77.USD","LU0225283273.USD","LU0353189680.USD","IE00B1XK9C88.USD","LU0689472784.USD","LU0174119429.USD","LU0456855351.SGD","SG9999015945.SGD","LU0109394709.USD","LU0316494557.USD","LU1323610961.USD","LU1988902786.USD","LU2063271972.USD","LU0058720904.USD","LU2111349929.HKD","LU2491050154.USD","TRUH","LU1917777945.USD","AGNG","LU0823434583.USD","LU0133085943.USD","LU2756315318.SGD","PJP","SG9999014906.USD","IHE","LU0471298694.HKD","SGXZ99366536.SGD","GB00BDT5M118.USD","LU1145028129.USD","LU2237443978.SGD","BK4585","IE00BJJMRY28.SGD","LU1629891620.HKD","LU2552382132.HKD","LU2213496289.HKD","IYH","XLV","LU0353189763.USD","LU1093756168.USD","LU0079474960.USD","HRTS","SG9999013999.USD","LU2028103732.USD","LU1267930730.SGD","LU0820561909.HKD","FHLC","CANC","LU0823434740.USD","LU0354030438.USD","LU1093756325.SGD","LU2324357040.USD","LU2264538146.SGD","IE00BK4W5M84.HKD","ELIL","LU1061106388.HKD","LU0210536198.USD","LU0787776722.HKD","LU2237443895.HKD","LU2471134879.HKD","LU0820562030.AUD","SG9999014880.SGD","MHIP","LU0238689110.USD","BK4588","SG9999001176.USD","LU1366192091.USD","LU0323591593.USD","LU1712237335.SGD","LU2896262040.SGD","LU0256863811.USD","IE00BWXC8680.SGD","LU1720051108.HKD","LU0820561818.USD","LU0203202063.USD","LU2237443465.HKD","IE00B2B36J28.USD","LU1551013425.SGD","LU2108987350.USD","LU1974910355.USD","IE00BKPKM429.USD","ILDR","LU2471134952.CNY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664694879","title":"通用電氣維諾華公司：與愛爾蘭國家電力公司達成協議，將為蘇格蘭高地的96兆瓦奇倫塞德風電場供應16台6.1兆瓦-158米型","url":"https://stock-news.laohu8.com/highlight/detail?id=2664694879","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664694879?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 19:17","pubTimestamp":1788434237,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0208291251.USD","LU0070302665.USD","IE00B2B36J28.USD","PPH","IE00BFTCPJ56.SGD","NVS","LU0320765489.SGD","BK4585","IE00BJT1NW94.SGD","BK4578","IE00BJJMRZ35.SGD","BK4532","BK4007","LU0211331839.USD","IE0009355771.USD","MEDX","IE0002141913.USD","BK4588","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664876096","title":"2026醫保國談將於9月5日舉行","url":"https://stock-news.laohu8.com/highlight/detail?id=2664876096","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664876096?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 19:02","pubTimestamp":1788433355,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1574","MEDX","BK1161","LNGR","06978","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664987512","title":"創新藥熱浪來襲，如何把握投資機會？","url":"https://stock-news.laohu8.com/highlight/detail?id=2664987512","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664987512?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 18:14","pubTimestamp":1788430440,"startTime":"0","endTime":"0","summary":"MACD金叉信号形成，这些股涨势不错！","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-09-03/doc-iniqpzpq4281019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","159992","BK1161","BK1574","MEDX","06978","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148741481","title":"Superluminal Medicines完成融資：Bvf Partners領投，英偉達、禮來等現有投資方跟投","url":"https://stock-news.laohu8.com/highlight/detail?id=1148741481","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148741481?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 18:09","pubTimestamp":1788430147,"startTime":"0","endTime":"0","summary":"Superluminal Medicines宣布完成新一轮融资，此轮融资由Bvf Partners领投。值得注意的是，包括英伟达、礼来、Cooley以及Gaingels在内的多家现有投资方亦参与了本轮投资，阵容堪称豪华。公司方面并未披露具体细节。投资方跨越科技与生物医药两大领域的布局，似乎也暗示着Superluminal Medicines未来的发展方向可能涉及计算驱动的药物发现。截至目前，Superluminal Medicines尚未透露本次融资的具体金额及公司估值。随着这笔资金的落袋，Superluminal Medicines接下来会有何动作？业界正拭目以待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESUM","LU1069347547.HKD","LU0096364046.USD","BK4598","LU1629891620.HKD","LU1548497426.USD","BK4585","LU0310799852.SGD","LU2047632596.USD","LU2054465674.USD","LU2552382058.USD","FHLC","BK4516","LU0234570918.USD","LU1316542783.SGD","LU1868837136.USD","DIPS","IE0004091025.USD","BK4503","LU0077335932.USD","LU1093756325.SGD","LU1868836591.USD","NVDU","LU1989772840.SGD","BK4549","BK4527","LU0203202063.USD","LU2458330243.SGD","LU1037948897.HKD","LU1718418525.SGD","BK4614","LU2750360641.GBP","LU0198837287.USD","NVDD","FDTX","LU0823434583.USD","LU2471134952.CNY","LU0724617625.USD","IE00BZ199S13.USD","LU0109392836.USD","IE0009356076.USD","IE0034235295.USD","LU0957808578.USD","IE00B775H168.HKD","LU0053666078.USD","LU2954938101.SGD","LU1983260115.SGD","LU0157215616.USD","LU1153585028.USD","LU0238689110.USD","IE00BJTD4V19.USD","LU2417539215.USD","BK4550","IE00B4YYXB79.USD","LU1291159041.SGD","LU1066053197.SGD","LU2491050154.USD","LU1400636574.HKD","LU1674673691.USD","LU1003077747.HKD","IE00B5949003.HKD","LU0289739699.SGD","IE00BQXX3D17.EUR","JGRO","LU0949170772.SGD","LU2097344431.USD","CURE","SG9999015986.USD","LU0256863902.USD","LU1691799644.USD","LU0494093205.USD","LU1721428933.USD","LU0553294199.USD","LU0882574139.USD","LU0256863811.USD","LU1244550494.USD","MEDX","LU0225283273.USD","LU1979441026.SGD","NVDL","IE00B2B36J28.USD","HK0000306701.USD","WISE","LU0175139822.USD","IXJ","LU0265550359.USD","ESLG","LU0965509283.SGD","LU1814569148.SGD","LU2461242641.AUD","LU2092937148.SGD","IE00BFSS8Q28.SGD","NVIW.SI","LU1064131342.USD","LU1815336760.USD","LU2999663052.SGD","SOXQ","SGXZ99366536.SGD","SNPE","CHPX","LU1144417596.USD","LU2413666426.HKD","LU2471134523.USD","LU0472753341.HKD","LU2089283258.USD","NVYY","BK4534","LU1720051108.HKD","LU0957791311.USD","ABFL","AIPI","LU2471134796.USD","NVDG","CANC","LU0444973449.USD","SGXZ81514606.USD","SG9999014575.USD","SGXZ31699556.SGD","IE00BJTD4N35.SGD","LU2089284900.SGD","NVDS.UK","BK4543","LU0345770308.USD","LU1242518857.USD","IE00BJJMRX11.SGD","LU0266013472.USD","LU2237443895.HKD","LU0061474705.USD","LU2237443978.SGD","LU0795875086.SGD","HK0000819398.USD","IE000W1ABFV2.USD","IE00BD6J9T35.USD","LU0289961442.SGD","SG9999015978.USD","HK0000306685.HKD","LU2552382215.SGD","IE000Q6AESB8.SGD","LU0942090050.USD","LU2456880835.USD","LU2168564495.EUR","LU2491050071.SGD","LU1429558221.USD","LU0127658192.USD","IE00B1BXHZ80.USD","LU0820561909.HKD","IE00BN29S564.USD","LU0353189680.USD","THNR","LU1699723380.USD","LU2168564065.EUR","BK4007","SG9999000418.SGD","LU2433249047.HKD","LU0345769631.USD","LU1720051017.SGD","LU2471134879.HKD","NVDW","SOXY","LU0345770993.USD","FTXH","LU0889565833.HKD","IE0004445239.USD","LU1366333091.USD","LU2111349929.HKD","IE00B4R5TH58.HKD","BK4587","IE0009355771.USD","LU2602419157.SGD","SNVDAmain","LU2413666699.HKD","LU1992135399.USD","LU2462591350.SGD","LU1435385759.SGD","LU0138981039.USD","LU1880398471.USD","LU0912757837.SGD","LU0345768740.USD","LU2023250504.SGD","LU1116320901.HKD","LU1923623000.USD","LU2097344357.USD","LU2347655156.SGD","PPH","LU0823434740.USD","LU2237443622.USD","LU0122379950.USD","PJP","LU1061106388.HKD","ILDR","LU0787776722.HKD","LU0267386448.USD","BK4605","SG9999014567.USD","IE0002141913.USD","IE00B3SWFQ91.USD","BK4551","BK4579","LU2028103732.USD","LU1066051498.USD","LU1119994496.HKD","SG9999015945.SGD","LU2236285917.USD","IE00BFSS7M15.SGD","ARTY","LU1935043023.USD","LU2065169927.USD","FAI","LU0187121727.USD","LU0353189763.USD","LU1935042215.USD","IE0005OL40V9.USD","HRTS","ANV","LU1244550577.SGD","LU2125909916.SGD","LU2543165471.USD","TRFK","LLY","LU0323591593.USD","LU0109391861.USD","LU0276348264.USD","WDNA","LU0689472784.USD","BK4567","IE0004445015.USD","IE00BKDWB100.SGD","LU0672654240.SGD","LU1868836757.USD","LU1935043536.SGD","LU0210528500.USD","LU2168564149.EUR","LU1066051225.USD","IE00BJLML261.HKD","LU0011850046.USD","LU2360106780.USD","LU0274383776.USD","EFIV","LU0545039389.USD","LU0708994859.HKD","HK0000320264.USD","LU0820562030.AUD","LU0081259029.USD","LU1934455863.HKD","LU0868494708.USD","LU2272731865.HKD","LU1989771016.USD","LU1989764664.SGD","LU2063271972.USD","NVDO","LU2290526834.HKD","USD","IE0003U64NQ7.SGD","LU1732799900.SGD","LU2326559502.SGD","LU0211328371.USD","LU0354030438.USD","LU0289960550.SGD","LU0965509010.AUD","LU0107464264.USD","IHE","LU1400636657.SGD","CMAG","LU0158827948.USD","BK4608","LU2125909247.SGD","LU0265550946.USD","SG9999013999.USD","LU0738911758.USD","LU2931357623.SGD","LU0385154629.USD","IE00BMPRXQ63.HKD","IE00BKPKM429.USD","LU0965508806.USD","LU0471298777.SGD","LU2108987350.USD","LU2322448957.HKD","LU0964807845.USD","NVC","LU1983299246.USD","LU0057025933.USD","LU2463028550.USD","LU1732800096.USD","LU1645745479.HKD","IE00BDRTCR15.USD","LU2361044949.HKD","LU0642271901.SGD","SG9999001176.USD","SG9999018857.SGD","LU1852331112.SGD","IE00BMPRXR70.SGD","LU0289739343.SGD","LU1988902786.USD","LU0788109477.HKD","LU2125909593.SGD","09788","IE000ITXATA3.USD","LU1035775433.USD","LU0106261372.USD","LU0354030511.USD","LU2756315318.SGD","IE00B19Z8W00.USD","LU2468319806.SGD","SMHX","LU0006306889.USD","MHIP","SOXX","AGOX","LU2357125470.USD","IE00BMPRXN33.USD","TYLG","LU1989772923.USD","TTXU","AGNG","LU1633808545.USD","LU0786609619.USD","LU1839511570.USD","LU1145028129.USD","LU2322448791.USD","NVDS","IE0001KFT4U8.USD","AIFD","LU3102509885.SGD","LU1712237335.SGD","MEDI","IE00BFTCPJ56.SGD","LU2237443549.SGD","TMED","LU2242649171.HKD","SG9999004303.SGD","SG9999002232.USD","BK4588","LU0109394709.USD","LU2430703251.USD","NVDB","LU0345769128.USD","HK0000914660.USD","LU0080751232.USD","LU2286300806.USD","LU1934455194.USD","SG9999014898.SGD","LU0868494617.USD","IE0009G5SDU7.USD","LU1861127337.USD","LU1778281490.HKD","SGXZ80539844.SGD","LU0528227936.USD","BK4581","BK4529","LU1880398554.USD","SHOC","LU2125909759.SGD","LU0432979614.USD","LU2089984988.USD","IE00B775SV38.USD","LU0689626769.HKD","LU2394011477.USD","LU0943347566.SGD","LU0056508442.USD","LU0823414551.USD","BK4554","LU0170899867.USD","LU2360106947.USD","LU1093756168.USD","IETC","LU0466842654.USD","LU2506951792.HKD","LU1267930490.SGD","LU0823421333.USD","LU1057294990.SGD","LU2023251221.USD","THMR","CNEQ","LU0251132253.USD","LU2430703095.HKD","LU2125154778.USD","BK4532","LU0395794307.EUR","LU1951198990.SGD","GDOC","LU2191332357.HKD","CHAT","LU1923622614.USD","LU0133085943.USD","IE00B5TLWC47.USD","SG9999015358.SGD","BK4592","BK4599","LU0234572021.USD","LU1066051811.HKD","BK4548","SG9999014542.SGD","RXL","LU0683600562.USD","LU1951200564.SGD","IE00BDCRKT87.USD","LU0070217475.USD","LU0128525929.USD","LU2244417387.USD","LU2491049909.HKD","LU0069063385.USD","LU0348723411.USD","IE00B19Z9505.USD","LU1815333072.USD","LU0211327993.USD","LU2168563687.JPY","IE0004086264.USD","LU2756315664.SGD","LU1267930573.SGD","LU1037948541.HKD","LU2462157665.USD","LU1232071149.USD","LU2077746001.SGD","LU0029864427.USD","LU0061474960.USD","LU2250418816.HKD","LU0979878070.USD","LU0476273544.USD","LU1127390331.HKD","SG9999017495.SGD","LU0823421416.USD","LU2089985449.USD","LU2087621335.USD","SGXZ51526630.SGD","LU0072462426.USD","SGXZ57979304.SGD","FTEC","07788","LU2237957902.USD","LU0417517546.SGD","LU0114720955.EUR","LU0320765059.SGD","SMH","HK0000914686.HKD","SNVD.UK","ELIL","LU1868837300.USD","LU2505996509.AUD","LU1914381329.SGD","LU2360032135.SGD","LLYZ","LU0557290698.USD","LU0048584097.USD","IXN","LU1261432733.SGD","LU2100268510.USD","LU2360107168.USD","NVD2.UK","SG9999015952.SGD","LFGY","LU1642822529.SGD","LU2106854487.HKD","LU1992135472.HKD","JDOC","LU1023059063.AUD","VT","LU2133065610.SGD","SG9999001424.SGD","NVDX","LU0882574055.USD","LU1935042991.SGD","IE0034235303.USD","LU0316494557.USD","LU2237443465.HKD","LU1267930730.SGD","LU0058720904.USD","NVD","IE00B1XK9C88.USD","LU2294711713.HKD","LU2087625088.SGD","LU2324357040.USD","LU0795875169.SGD","LU1803068979.SGD","LU0320765992.SGD","LU2271345857.HKD","HK0000532082.HKD","LU2430703178.SGD","LU1861215975.USD","LU1035773651.USD","NVD3.UK","LU1861220033.SGD","LU2403377893.USD","LU0456855351.SGD","LU0823414478.USD","LU0719512351.SGD","LU0985320562.USD","LU1496350502.SGD","NULC","BK4533","LU1366192091.USD","LU0308772762.SGD","LU2247934214.USD","LU2746668974.SGD","SG9999002224.SGD","LU1551013342.USD","2NVD.UK","LU1551013425.SGD","LU1280957306.USD","SG9999001176.SGD","LU2242650005.HKD","LU2264538146.SGD","LU2452424414.USD","LU1923622291.USD","XLV","LU1116320737.USD","3NVD.UK","BK4612","LU0079474960.USD","IE00BJJMRY28.SGD","LU0323239441.USD","LU2357305700.SGD","LU2065170008.USD","LU0061475181.USD","LU2860962120.EUR","LU1084165304.USD","XLK","TRUH","LU2083900584.USD","IE00BJT1NW94.SGD","LU0511384066.AUD","LU2896262040.SGD","SG9999015341.SGD","LU2637965513.SGD","SG9999014914.USD","LU0210533765.USD","IE00BQXX3C00.GBP","LU2125154935.USD","VGT","LU0471298694.HKD","NVDQ","LU2462591277.SGD","LU1804176565.USD","LU0708995401.HKD","LU0342679015.USD","LU1821325948.USD","LU2265009873.SGD","LU1496350171.SGD","LU0347712357.USD","IE00BWXC8680.SGD","IE00B3M56506.USD","OZEM","LU0174119429.USD","07388","LU0661504455.SGD","LLII","LU0124676726.USD","LU0965509101.SGD","NVDA","LU2213496289.HKD","LU0323240290.USD","LU0726765562.USD","LU2237438978.USD","LU0310800379.SGD","LU2211815571.USD","IE000KEQY171.SGD","LU1069344957.HKD","LU2361045086.USD","LU2272731600.USD","LU1674673428.USD","LU2473716301.USD","LU1244550221.USD","LU2592432038.USD","LU2272731782.SGD","LU0820561818.USD","VHT","GAMR","09388","LU2065171311.SGD","LU2168564222.USD","LU0154236417.USD","LU2237957811.SGD","LU2381873111.SGD","SG9999014559.SGD","LU1323610961.USD","LU2505996681.GBP","BK4141","IE00BK4W5M84.HKD","IE00BQXX3F31.USD","LU1974910355.USD","LU2023250330.USD","IE00BKVL7J92.USD","LU0158827781.USD","LU1623119135.USD","LU2065171402.SGD","NVDY","LU2487616109.SGD","LU0861579265.USD","LU1868836914.USD","LU2420271590.USD","LU0096362180.USD","HK0000304805.HKD","LU0094547139.USD","LU1400636491.USD","LU1989764748.USD","LU1571399168.USD","SPTE","LU2279689827.SGD","LU1935042488.USD","LU0345768153.USD","LU0390134368.USD","SG9999014906.USD","METV","LU2249611893.SGD","LU2237443382.USD","LU2092627202.USD","LU1670756490.USD","IE00BZ1G4Q59.USD","IE00B3S45H60.SGD","IE0034235188.USD","LU2552382132.HKD","LU2148611432.USD","LU2458330169.SGD","LU1202635105.USD","CLSE","LU0215105999.USD","IE00BHPRN162.USD","TTEQ","LU2347655073.USD","LU2112291526.USD","LU0889565916.HKD","SG9999014880.SGD","LU1791710400.SGD","LU0640476718.USD","IE00BJJMRZ35.SGD","USXF","IE00BYXW3230.USD","LU1934455277.USD","IE00B4JS1V06.HKD","IYH","IE000YTNTUN2.SGD","IE00BK4W5L77.USD","LU0082616367.USD","SGXZ23171101.USD","LU2746668461.USD","LU1791710582.SGD","IE00B19Z8X17.USD","LU0097036916.USD","IE00B7KXQ091.USD","LU0143551892.USD","LU0203201768.USD","SG9999018865.SGD","LLYX","HK0000304797.USD","LU1917777945.USD","NVII","LU2750360997.AUD","HK0000320223.HKD","ELIS","LU0210536198.USD","LU2361044865.SGD","TEK","LU0823416689.USD","ROM","GB00BDT5M118.USD","LU1242518931.SGD","LU0444971666.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664987559","title":"浩歐博(688656.SH)子公司獲得13項醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664987559","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664987559?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 18:04","pubTimestamp":1788429879,"startTime":"0","endTime":"0","summary":"智通财经APP讯，浩欧博(688656.SH)发布公告，公司全资子公司湖南浩欧博生物医药有限公司于近日获得13项由湖南省药品监督管理局核准签发的医疗器械注册证。上述医疗器械注册证的取得，进一步丰富了公司化学发光平台检测菜单，有助于提升公司市场综合竞争力，对公司及子公司的可持续性发展将产生积极影响和促进作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491597.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","MDEV","AGNG","BK1583","GDOC","HART","IEIH","MEDX","PTH","BK1100","RSPH","688656","159883","BK0239","LNGR","LGHT","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664875311","title":"康哲藥業(00867)：創新藥磷酸蘆可替尼乳膏百盧妥®增加特應性皮炎適應症(AD) 中國上市許可申請獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2664875311","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664875311?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 18:01","pubTimestamp":1788429695,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业 发布公告，旗下德镁医药有限公司已于2026年9月2日获得中国国家药品监督管理局批准磷酸芦可替尼乳膏百卢妥轻中度特应性皮炎的新药上市许可申请，并于2026年九月3日获得药品注册证书。2026年1月，百卢妥中国NDA获批，成为中国批准的首款用于白癜风治疗的外用 JAK抑制剂。继百卢妥获批白癜风适应症后，此次AD适应症NDA获批，将进一步拓展产品的临床应用空间。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491592.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","06978","IE00BYV24P56.USD","SG9999015945.SGD","SG9999015986.USD","MEDX","00867","BK1574","IE00BGHQDM52.EUR","SG9999004220.SGD","159992","IBBQ","IE00BVYPNP33.GBP","BK1161","SG9999015952.SGD","IE00BMCWC346.EUR","IE00BVYPNQ40.USD","SG9999015978.USD","AD","BK1593","BK1191","LNGR","LU2488822045.USD","BK4132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664731738","title":"一品紅(300723.SZ)：痛風創新藥AR882治療痛風伴高尿酸血癥患者Ⅲ期臨床研究達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2664731738","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664731738?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 17:47","pubTimestamp":1788428833,"startTime":"0","endTime":"0","summary":"智通财经APP讯，一品红 发布公告，公司全资子公司广州瑞安博医药科技有限公司牵头组织开展的AR882胶囊治疗痛风伴高尿酸血症患者Ⅱ/Ⅲ期临床试验，于近日获得顶线分析数据。初步统计结果表明，AR882在痛风伴高尿酸血症参与者中表现出积极的疗效及良好的安全性，试验结果理想，达到预期目的。AR882克服了雷西纳德和苯溴马隆的缺点，能够与尿酸转运蛋白长效结合，延长抑制作用的时间，临床结果显示其药效长达24小时。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491579.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159992","300723","BK0239","BK1574","LNGR","MEDX","BK1161","IBBQ","06978"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":12,"totalSize":258,"code":"91000000","status":"200"}]}}